Episode Details

Back to Episodes
Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China

Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China

Published 8 years, 3 months ago
Description
How did the FDA become so friendly to the drug industry? The thorny issue of using 23andMe to unite families separated at the border, and Rebecca explains how drugs are priced in China.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us